Design Therapeutics, Inc. (DSGN) stock
DSGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$9.84−0.08 (-0.81%)
Close on Nov 17, 2026Market cap $615.80MP/E –Yield –
Design Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Design Therapeutics's enterprise value was $466.59M on Nov 11, 2026, against $328.89M a year earlier. Over the last 5 years it ranged from -$188.90M to $788.64M, with a median of $98.62M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $466.59M | +42.1% |
| 2025 | Dec 31, 2025 | $328.32M | +244.7% |
| 2024 | Dec 31, 2024 | $95.25M | – |
| 2023 | Dec 29, 2023 | -$142.51M | -162.3% |
| 2022 | Dec 30, 2022 | $228.72M | -71.0% |
| 2021 | Dec 31, 2021 | $788.64M | – |
See a number that looks wrong?